搜索临床试验以:Iodine I 131 Tositumomab
总计494381个结果
-
National Institute of Allergy and Infectious Diseases...Abbott; Glaxo Wellcome终止
-
Jichi Medical UniversityEli Lilly and Company; Boehringer Ingelheim完全的
-
AbbVie (prior sponsor, Abbott)Veeda Clinical Research完全的
-
University of ManitobaInovio Pharmaceuticals完全的
-
University of Florida撤销
-
University of Rome Tor Vergata完全的2型糖尿病 | Diabetic Dyslipidemia意大利
-
Bristol-Myers Squibb完全的
-
Bristol-Myers Squibb完全的
-
Embry-Riddle Aeronautical UniversityNational Development and Research Institutes, Inc.招聘中
-
Frederic PRAT, MD, PhD招聘中Malignant Biliary Stenosis法国
-
Centre for Addiction and Mental HealthThe Physicians' Services Incorporated Foundation完全的
-
Roswell Park Cancer InstituteAIM ImmunoTech Inc.终止
-
Barbara Ann Karmanos Cancer Institute完全的
-
Memorial Sloan Kettering Cancer CenterPfizer; NATL COMP CA NETWORK完全的
-
Brock UniversityDr. Peter C. Fritz, Periodontal Wellness & Implant Surgery完全的
-
Dana-Farber Cancer InstituteChildren's Hospital of Philadelphia; Boston Children's Hospital完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)终止既往骨髓增生异常综合征引起的急性髓性白血病 | 慢性粒单核细胞白血病 | 先前治疗过的骨髓增生异常综合征 | 缓解期成人急性髓性白血病 | 缓解期成人急性淋巴细胞白血病 | 难治性贫血伴原始细胞过多 | 难治性环状铁粒幼细胞性贫血 | 难治性血细胞减少伴多系发育不良 | 难治性血细胞减少伴多系发育不良和环状铁粒幼细胞 | 存在 CD45 阳性肿瘤细胞美国
-
National Cancer Institute (NCI)完全的复发性甲状腺癌 | IVA 期滤泡性甲状腺癌 | IVA 期甲状腺乳头状癌 | IVB 期滤泡性甲状腺癌 | IVB 期乳头状甲状腺癌 | IVC 期滤泡性甲状腺癌 | IVC 期甲状腺乳头状癌美国
-
Azienda Sanitaria-Universitaria Integrata di UdineUniversity of Udine邀请报名
-
Bristol-Myers Squibb完全的
-
Rafic Farah, MD完全的
-
Kaohsiung Veterans General Hospital.完全的
-
Centre for Addiction and Mental HealthOntario Ministry of Health and Long Term Care完全的
-
The Children's InstituteDuquesne University; Health Resources and Services Administration (HRSA)完全的
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka America Pharmaceutical完全的